Glenmark Pharmaceuticals receives sANDA approval for Abiraterone Acetate Tablets USP, 500 mg \
2 min read
\
\

Glenmark Pharmaceuticals receives sANDA approval for Abiraterone Acetate Tablets USP, 500 mg

20-May-2022
Mumbai (Maharashtra) [India], May 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Abiraterone Acetate Tablets USP, 500 mg, the generic version of Zytiga®1 Tablets, 500 mg, of Janssen Biotech Inc.
20-May-2022 Business
\
Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent \
2 min read
\
\

Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent

09-May-2022
Mumbai (Maharashtra) [India], May 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent, the generic version of Enstilar®1 Foam, 0.005 per cent|0.064 per cent, of Leo Pharma AS.
09-May-2022 Business
\
Glenmark receives the ‘India Pharma Innovation of the Year’ Award from the Government of India \
3 min read
\
\

Glenmark receives the ‘India Pharma Innovation of the Year’ Award from the Government of India

27-Apr-2022
Mumbai (Maharashtra) [India], April 27 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, today received the 'India Pharma Innovation of the Year' Award and was adjudged runners-up in the 'India Pharma CSR of the Year' category, as part of the India Pharma & India Medical Device Awards 2022.
27-Apr-2022 Business
\
Glenmark Pharmaceuticals makes it to the prestigious Dow Jones Sustainability emerging markets index for the fourth consecutive year \
2 min read
\
\

Glenmark Pharmaceuticals makes it to the prestigious Dow Jones Sustainability emerging markets index for the fourth consecutive year

16-Nov-2021
Mumbai (Maharashtra) [India], November 16 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets for the fourth consecutive year.
16-Nov-2021 Business
\
Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes \
3 min read
\
\

Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes

26-Oct-2021
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
26-Oct-2021 Health
\
Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes \
3 min read
\
\

Glenmark Pharmaceuticals launches fixed-drug combination for management of type 2 diabetes

26-Oct-2021
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
26-Oct-2021 Health
\